HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Effect of triple costimulation blockade on islet allograft survival in sensitized mice.

AbstractBACKGROUND:
Islet allograft rejection in sensitized recipients is difficult to control by costimulation blockade using anti-CD154 and cytotoxic T-lymphocyte antigen-4 immunoglobulin (CTLA4Ig). Because leukocyte function antigen (LFA) 1 is highly expressed on memory T cells, adding an LFA-1 blockade may inhibit memory T-cell activities. We examined the effects on islet allograft survival of triple costimulation blockade in presensitized recipient mice.
METHODS:
C57BL/6 mice were sensitized by transplantation under the kidney capsule or intraperitoneal injection of Balb/c islets. Four weeks after transplantation, sensitization was confirmed by flow-cytometric detection of alloreactive antibodies. Diabetes was induced by a single intravenous injection of streptozotocin. Recipients were transplanted with 200 Balb/c islets under the right kidney capsule. Graft function was assessed by daily blood glucose and body weight records. Transplanted animals were divided into 3 treatment groups: group 1, control antibody; group 2, anti-CD154 and CTLA-4 Ig double therapy; group 3, anti-CD154, CTLA4Ig, and anti-LFA-1 triple therapy. Injections were administered every second day from day -2 to day 8.
RESULTS:
Naïve mice rejected islet allografts between days 7 and 29 (mean 16 +/- 6 d; n = 5), sensitized mice in group 1 between days 0 and 14 (mean 7 +/- 5 d; n = 8), in group 2 between days 4 and 16 (mean 8 +/- 4 d; n = 7), and in group 3 between days 4 and 26 (mean 11 +/- 7 d; n = 10).
CONCLUSION:
Triple costimulation blockade with anti-CD154, CTLA4Ig, and anti-LFA-1 was not sufficient to improve islet allograft survival in sensitized recipients.
AuthorsR Diab, T Iwata, M Corbascio, A Tibell, H Ekberg, J Holgersson, M Kumagai-Braesch
JournalTransplantation proceedings (Transplant Proc) 2010 Jul-Aug Vol. 42 Issue 6 Pg. 2109-11 ISSN: 1873-2623 [Electronic] United States
PMID20692420 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2010 Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD
  • Blood Glucose
  • CTLA-4 Antigen
  • Ctla4 protein, mouse
  • Immunoglobulin G
Topics
  • Animals
  • Antigens, CD (immunology)
  • Blood Glucose (metabolism)
  • CTLA-4 Antigen
  • Diabetes Mellitus, Experimental (blood, surgery)
  • Graft Rejection (blood)
  • Graft Survival (physiology)
  • Immunoglobulin G (immunology)
  • Islets of Langerhans Transplantation (immunology, pathology, physiology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred C57BL
  • Reoperation
  • Transplantation, Homologous (immunology, pathology, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: